Cargando…
Statins in COVID-19: Is there any foundation?()
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of coronavirus disease 2019 (COVID-19). Acute respiratory distress syndrome is the main cause of death from COVID-19 and occurs due to an exaggerated inflammatory response that causes the release of pro-inflammatory cyt...
Autores principales: | Lima Martínez, Marcos M., Contreras, Miguel A., Marín, Waleskha, D’Marco, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648510/ http://dx.doi.org/10.1016/j.artere.2020.11.004 |
Ejemplares similares
-
Estatinas en COVID-19: ¿existe algún fundamento?
por: Lima Martínez, Marcos M., et al.
Publicado: (2020) -
COVID-19 y diabetes mellitus: una relación bidireccional
por: Lima-Martínez, Marcos M., et al.
Publicado: (2021) -
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017) -
Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease
por: D’Marco, Luis, et al.
Publicado: (2020) -
Statins in COVID-19 Therapy
por: Olszewska-Parasiewicz, Justyna, et al.
Publicado: (2021)